Faculty Articles
Title
Flibanserin (Addyi): The First FDA-Approved Treatment for Female Sexual Interest/Arousal Disorder in Premenopausal Women
Publication Title
P T
Volume
42
Issue
4
Publication Date / Copyright Date
4-1-2017
First Page
237
Last Page
241
Abstract
Flibanserin (Addyi) for female sexual interest/arousal disorder in premenopausal women.
Disciplines
Medicine and Health Sciences | Pharmacy and Pharmaceutical Sciences
NSUWorks Citation
English, Clayton; Muhleisen, Anne; and Rey, Jose A., "Flibanserin (Addyi): The First FDA-Approved Treatment for Female Sexual Interest/Arousal Disorder in Premenopausal Women" (2017). Faculty Articles. 119.
https://nsuworks.nova.edu/hpd_corx_facarticles/119
